KEGG   PATHWAY: cbrc04310
Entry
cbrc04310                   Pathway                                
Name
Wnt signaling pathway - Corvus brachyrhynchos (American crow)
Description
Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.
Class
Environmental Information Processing; Signal transduction
Pathway map
cbrc04310  Wnt signaling pathway
cbrc04310

Other DBs
GO: 0016055
Organism
Corvus brachyrhynchos (American crow) [GN:cbrc]
Gene
103611217  [KO:K26734]
103611219  APC; LOW QUALITY PROTEIN: adenomatous polyposis coli protein [KO:K02085]
103611322  WNT10A; protein Wnt-10a [KO:K01357]
103611388  MAPK9; mitogen-activated protein kinase 9 isoform X2 [KO:K04440] [EC:2.7.11.24]
103611405  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
103611480  CSNK1A1; casein kinase I isoform X4 [KO:K08957] [EC:2.7.11.1]
103611508  [KO:K04496] [EC:1.1.1.428]
103611915  WNT1; proto-oncogene Wnt-1 [KO:K03209]
103612215  CCDC88C; protein Daple [KO:K25811]
103612347  FZD1; frizzled-1 [KO:K02432]
103612397  RYK; tyrosine-protein kinase RYK isoform X1 [KO:K05128] [EC:2.7.10.1]
103612399  SENP2; sentrin-specific protease 2 isoform X1 [KO:K03345] [EC:3.4.22.68]
103612446  APCDD1; protein APCDD1 [KO:K25812]
103612622  FZD7; frizzled-7 [KO:K02432]
103612625  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
103612948  FZD6; frizzled-6 [KO:K02376]
103613086  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
103613088  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X1 [KO:K07861]
103613098  LRP6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
103613126  NOTUM; palmitoleoyl-protein carboxylesterase NOTUM isoform X2 [KO:K19882] [EC:3.1.1.98]
103613285  FZD3; frizzled-3 isoform X1 [KO:K02329]
103613308  NLK; serine/threonine-protein kinase NLK [KO:K04468] [EC:2.7.11.24]
103613515  VANGL2; vang-like protein 2 [KO:K04510]
103613830  WNT11; protein Wnt-11 isoform X1 [KO:K01384]
103613888  VANGL1; vang-like protein 1 isoform X1 [KO:K04510]
103614017  GSK3B; glycogen synthase kinase-3 beta [KO:K03083] [EC:2.7.11.26]
103614056  [KO:K00408]
103614289  RHOA; transforming protein RhoA [KO:K04513]
103614372  RSPO2; LOW QUALITY PROTEIN: R-spondin-2 [KO:K23097]
103614398  WNT5A; protein Wnt-5a [KO:K00444]
103614417  RUVBL1; ruvB-like 1 [KO:K04499] [EC:5.6.2.4]
103614609  CER1; cerberus [KO:K01645]
103614663  WNT8A; protein Wnt-8a [KO:K00714]
103614681  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
103614692  TCF7; transcription factor 7 [KO:K02620]
103614709  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
103614785  PRICKLE1; prickle-like protein 1 [KO:K04511]
103614804  WIF1; wnt inhibitory factor 1 [KO:K01691]
103614823  LGR5; leucine-rich repeat-containing G-protein coupled receptor 5 [KO:K04308]
103614854  WNT2; protein Wnt-2 [KO:K00182]
103615008  PPP3CC; LOW QUALITY PROTEIN: serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform [KO:K04348] [EC:3.1.3.16]
103615058  JUN; transcription factor AP-1 [KO:K04448]
103615312  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
103615420  SFRP1; secreted frizzled-related protein 1 [KO:K02166]
103615449  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
103615516  PRKCB; LOW QUALITY PROTEIN: protein kinase C beta type [KO:K19662] [EC:2.7.11.13]
103615654  SMAD4; mothers against decapentaplegic homolog 4 [KO:K04501]
103615760  CUL1; cullin-1 isoform X2 [KO:K03347]
103615789  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
103615962  ZNRF3; LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase ZNRF3 [KO:K16273] [EC:2.3.2.27]
103616000  FZD10; frizzled-10 [KO:K02842]
103616111  CSNK2A1; casein kinase II subunit alpha [KO:K03097] [EC:2.7.11.1]
103616151  RSPO4; R-spondin-4 [KO:K23099]
103616186  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
103616275  TCF7L2; transcription factor 7-like 2 isoform X3 [KO:K04491]
103616605  FZD5; frizzled-5 [KO:K02375]
103616712  FZD4; frizzled-4 [KO:K02354]
103616873  RSPO1; R-spondin-1 isoform X1 [KO:K19471]
103617190  PPP3R1; calcineurin subunit B type 1 isoform X2 [KO:K06268]
103617325  DKK2; dickkopf-related protein 2 [KO:K02165]
103617377  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
103617392  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
103617426  SFRP2; secreted frizzled-related protein 2 [KO:K02176]
103617575  TBL1X; LOW QUALITY PROTEIN: F-box-like/WD repeat-containing protein TBL1X [KO:K04508]
103617780  CACYBP; calcyclin-binding protein [KO:K04507]
103617960  MMP7; matrilysin [KO:K01397] [EC:3.4.24.23]
103618019  APCDD1L; protein APCDD1-like [KO:K25812]
103618070  RAC2; ras-related C3 botulinum toxin substrate 2 isoform X2 [KO:K07860]
103618091  [KO:K08960] [EC:2.7.11.1]
103618094  CBY1; protein chibby homolog 1 [KO:K23402]
103618139  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 [KO:K17332]
103618243  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
103618244  EP300; LOW QUALITY PROTEIN: histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
103618341  FZD9; frizzled-9 [KO:K02842]
103618351  RNF43; E3 ubiquitin-protein ligase RNF43 [KO:K15694] [EC:2.3.2.27]
103618361  FBXW11; F-box/WD repeat-containing protein 11 isoform X2 [KO:K03362]
103618702  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
103618758  CTNND2; catenin delta-2 [KO:K23491]
103618828  DAAM1; disheveled-associated activator of morphogenesis 1 isoform X2 [KO:K04512]
103618994  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
103619015  WISP1; WNT1-inducible-signaling pathway protein 1 isoform X2 [KO:K22471]
103619207  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
103619304  RSPO3; R-spondin-3 [KO:K23098]
103619457  [KO:K04501]
103619498  LGR6; LOW QUALITY PROTEIN: leucine-rich repeat-containing G-protein coupled receptor 6 [KO:K08399]
103619786  TLE3; LOW QUALITY PROTEIN: transducin-like enhancer protein 3 [KO:K04497]
103619863  [KO:K04497]
103620084  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
103620086  AXIN2; axin-2 [KO:K04385]
103620183  NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333]
103620199  SIAH1; E3 ubiquitin-protein ligase SIAH1 isoform X1 [KO:K04506] [EC:2.3.2.27]
103620240  CSNK2A2; casein kinase II subunit alpha' [KO:K03097] [EC:2.7.11.1]
103620244  TCF7L1; LOW QUALITY PROTEIN: transcription factor 7-like 1 [KO:K04490]
103620297  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta [KO:K04515] [EC:2.7.11.17]
103620314  NKD1; protein naked cuticle homolog 1 [KO:K03213]
103620357  WNT2B; protein Wnt-2b [KO:K00182]
103620477  AXIN1; axin-1 [KO:K02157]
103620491  CREBBP; CREB-binding protein [KO:K04498] [EC:2.3.1.48]
103620626  BAMBI; BMP and activin membrane-bound inhibitor homolog [KO:K10162]
103620701  LRP5; low-density lipoprotein receptor-related protein 5 isoform X2 [KO:K03068]
103620786  PSEN1; presenilin-1 isoform X1 [KO:K04505] [EC:3.4.23.-]
103621084  DAAM2; disheveled-associated activator of morphogenesis 2 isoform X1 [KO:K04512]
103621367  ROR2; tyrosine-protein kinase transmembrane receptor ROR2 [KO:K05123] [EC:2.7.10.1]
103621450  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
103621506  SERPINF1; pigment epithelium-derived factor [KO:K19614]
103621704  ROR1; inactive tyrosine-protein kinase transmembrane receptor ROR1 isoform X1 [KO:K05122] [EC:2.7.10.1]
103621813  [KO:K04497]
103622098  WNT16; protein Wnt-16 [KO:K01558]
103622124  [KO:K04497]
103622161  [KO:K04497]
103622199  SOST; sclerostin [KO:K16834]
103622240  CTNNBIP1; beta-catenin-interacting protein 1 [KO:K04493]
103622310  DVL1; segment polarity protein dishevelled homolog DVL-1 [KO:K02353]
103622357  MAPK10; mitogen-activated protein kinase 10 isoform X4 [KO:K04440] [EC:2.7.11.24]
103622673  WNT3; proto-oncogene Wnt-3 [KO:K00312]
103622681  FZD2; frizzled-2 [KO:K02235]
103622698  WNT9B; protein Wnt-9b [KO:K01064]
103622782  ROCK2; rho-associated protein kinase 2 isoform X1 [KO:K17388] [EC:2.7.11.1]
103622915  [KO:K08110]
103622983  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
103623017  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
103623312  [KO:K01384]
103623342  CCND2; G1/S-specific cyclin-D2 isoform X1 [KO:K10151]
103623571  INVS; inversin isoform X1 [KO:K19626]
103623727  SIRT1; NAD-dependent protein deacetylase sirtuin-1 [KO:K11411] [EC:2.3.1.286]
103623917  WNT9A; protein Wnt-9a [KO:K01064]
103623918  WNT3A; LOW QUALITY PROTEIN: protein Wnt-3a [KO:K00312]
103624290  FRZB; secreted frizzled-related protein 3 [KO:K25481]
103624353  PRICKLE2; prickle-like protein 2 isoform X1 [KO:K04511]
103624416  [KO:K05858] [EC:3.1.4.11]
103624446  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma [KO:K04515] [EC:2.7.11.17]
103624456  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X6 [KO:K04348] [EC:3.1.3.16]
103624472  WNT8B; protein Wnt-8b [KO:K00714]
103624489  MAPK8; mitogen-activated protein kinase 8 isoform X2 [KO:K04440] [EC:2.7.11.24]
103624550  BTRC; F-box/WD repeat-containing protein 1A isoform X1 [KO:K03362]
103624640  SFRP5; secreted frizzled-related protein 5 [KO:K02222]
103624660  LZTS2; leucine zipper putative tumor suppressor 2 [KO:K26471]
103624690  WNT5B; LOW QUALITY PROTEIN: protein Wnt-5b [KO:K00444]
103624745  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
103624796  LGR4; leucine-rich repeat-containing G-protein coupled receptor 4 isoform X1 [KO:K04309]
103625094  TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1 isoform X1 [KO:K04508]
103625128  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X2 [KO:K02353]
103625292  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
103625312  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
103625542  WNT6; protein Wnt-6 [KO:K00445]
103625645  CTBP1; C-terminal-binding protein 1 isoform X2 [KO:K04496] [EC:1.1.1.428]
Compound
C00076  Calcium cation
Reference
  Authors
Hatsell S, Rowlands T, Hiremath M, Cowin P.
  Title
Beta-catenin and Tcfs in mammary development and cancer.
  Journal
J Mammary Gland Biol Neoplasia 8:145-58 (2003)
DOI:10.1023/A:1025944723047
Reference
  Authors
Yang Y.
  Title
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.
  Journal
Birth Defects Res Part C Embryo Today 69:305-17 (2003)
DOI:10.1002/bdrc.10026
Reference
  Authors
Kalderon D.
  Title
Similarities between the Hedgehog and Wnt signaling pathways.
  Journal
Trends Cell Biol 12:523-31 (2002)
DOI:10.1016/S0962-8924(02)02388-7
Reference
  Authors
Nusse R.
  Title
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
  Journal
Development 130:5297-305 (2003)
DOI:10.1242/dev.00821
Reference
  Authors
Jope RS, Johnson GV.
  Title
The glamour and gloom of glycogen synthase kinase-3.
  Journal
Trends Biochem Sci 29:95-102 (2004)
DOI:10.1016/j.tibs.2003.12.004
Reference
  Authors
Veeman MT, Axelrod JD, Moon RT.
  Title
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
  Journal
Dev Cell 5:367-77 (2003)
DOI:10.1016/S1534-5807(03)00266-1
Reference
  Authors
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.
  Title
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.
  Journal
Nat Cell Biol 3:628-36 (2001)
DOI:10.1038/35083016
Reference
  Authors
Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E
  Title
The way Wnt works: Components and mechanism.
  Journal
Growth Factors 31:1-31 (2013)
DOI:10.3109/08977194.2012.752737
Reference
  Authors
Carethers JM
  Title
Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.
  Journal
Gastroenterology 137:33-6 (2009)
DOI:10.1053/j.gastro.2009.05.011
Reference
  Authors
Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG
  Title
The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.
  Journal
J Biol Chem 283:33053-8 (2008)
DOI:10.1074/jbc.M804039200
Reference
  Authors
Niehrs C
  Title
The complex world of WNT receptor signalling.
  Journal
Nat Rev Mol Cell Biol 13:767-79 (2012)
DOI:10.1038/nrm3470
Reference
  Authors
Abou Ziki MD, Mani A
  Title
Wnt signaling, a novel pathway regulating blood pressure? State of the art review.
  Journal
Atherosclerosis 262:171-178 (2017)
DOI:10.1016/j.atherosclerosis.2017.05.001
Reference
  Authors
He Y, Ki H, Kim H, Kim K
  Title
delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.
  Journal
Cell Biol Int 39:954-61 (2015)
DOI:10.1002/cbin.10465
Reference
  Authors
Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M
  Title
The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.
  Journal
Biochem Biophys Res Commun 532:406-413 (2020)
DOI:10.1016/j.bbrc.2020.08.066
Reference
  Authors
Yiew NKH, Chatterjee TK, Tang YL, Pellenberg R, Stansfield BK, Bagi Z, Fulton DJ, Stepp DW, Chen W, Patel V, Kamath VM, Litwin SE, Hui DY, Rudich SM, Kim HW, Weintraub NL
  Title
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.
  Journal
J Biol Chem 292:6312-6324 (2017)
DOI:10.1074/jbc.M116.758078
Related
pathway
cbrc04010  MAPK signaling pathway
cbrc04110  Cell cycle
cbrc04115  p53 signaling pathway
cbrc04120  Ubiquitin mediated proteolysis
cbrc04350  TGF-beta signaling pathway
cbrc04510  Focal adhesion
cbrc04520  Adherens junction
KO pathway
ko04310   

DBGET integrated database retrieval system